공간유전체학 및 전사체학 시장 : 제품, 기술, 최종 사용자별 - 세계 예측(2025-2030년)

The Spatial Genomics & Transcriptomics Market was valued at USD 782.33 million in 2023, expected to reach USD 879.03 million in 2024, and is projected to grow at a CAGR of 13.62%, to USD 1,913.12 million by 2030.

Spatial genomics and transcriptomics represent cutting-edge fields that focus on the spatial organization and expression of genes within tissues. The necessity of these fields stems from the limitations of conventional genomic technologies, which often disregard the spatial context of gene expression, thus missing critical insights into cellular function, disease progression, and tissue architecture. Applications are vast, ranging from cancer research and neuroscience to developmental biology and personalized medicine, where understanding the spatial arrangement of gene activity can inform targeted therapies and interventions. Key end-users include academic research institutions, biotechnology companies, and pharmaceutical industries focusing on drug discovery and development.

Market insights highlight that the increasing demand for high-resolution spatial imaging and comprehensive molecular profiling is driving growth, fueled by technological advancements and decreasing sequencing costs. Additionally, the integration of artificial intelligence and machine learning in data analysis provides new dimensions for extracting meaningful insights from complex spatial data. However, challenges include technical constraints such as data complexity, high costs of high-resolution imaging technologies, and the need for highly skilled professionals. Regulatory hurdles and ethical considerations regarding data privacy in genomics also pose limitations.

Potential opportunities lie in developing more cost-effective and accessible technologies, improving data integration methods, and enhancing user-friendly analytical software. Increased collaboration between industry and academic sectors can spur innovation, while investment in R&D can lead to breakthroughs in multiplexing capabilities and single-cell analysis techniques. The market is rapidly evolving, underscored by increasing commercial interest and strategic partnerships aimed at expanding product portfolios. Best areas for innovation include bioinformatics software for data visualization, platforms for integrating multi-omics data, and novel single-cell spatial assays. This dynamic market requires continual adaptation to technological advancements and shifting regulatory landscapes, making thorough market analysis crucial for sustained growth and competitiveness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spatial Genomics & Transcriptomics Market

The Spatial Genomics & Transcriptomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic diseases and need for designing accurate and effective drugs
  • Improving regulatory and ethical acceptance of genomics and sequencing technologies
  • Emerging use of spatial analysis to advance precision medicine & diagnostics
• Market Restraints
  • Limited awareness among healthcare professionals about genomic medicine in developing economies
• Market Opportunities
  • Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
  • Rising public and private funding for genomics & transcriptomics research
• Market Challenges
  • Reimbursement inconsistency and uncertainty in gene & single-cell sequencing

Porter's Five Forces: A Strategic Tool for Navigating the Spatial Genomics & Transcriptomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spatial Genomics & Transcriptomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spatial Genomics & Transcriptomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spatial Genomics & Transcriptomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spatial Genomics & Transcriptomics Market

A detailed market share analysis in the Spatial Genomics & Transcriptomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spatial Genomics & Transcriptomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spatial Genomics & Transcriptomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spatial Genomics & Transcriptomics Market

A strategic analysis of the Spatial Genomics & Transcriptomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10X Genomics, Inc., Akoya Biosciences, Inc., Arima Genomics, Inc., AtlasXomics Inc., Axcelead Drug Discovery Partners Inc., BGI Australia, Bio-Techne Corporation, BioSpyder Technologies Inc., Bruker Corporation, Bucher Biotec AG, CD Genomics, CeGaT GmbH, Dovetail Genomics, LLC, Easi-Genomics, Enzo Life Sciences, Inc., Eurofins Genomics, Fulgent Genetics, Genomic Vision SA, Illumina, Inc., Indivumed Group, Ionpath, Inc., Lunaphore Technologies S.A., Miltenyi Biotec, Nanostring Technologies, Inc., Natera Inc., Novogene Co, Ltd., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., PT Pandu Biosains, Rarecyte, Inc, Rebus Biosystems, Inc., Resolve Biosciences GmbH, S2 Genomics, Inc., Seven Bridges Genomics, Single Cell Discoveries, Single Technologies AB, Singular Genomics System, Inc., Spatial Genomics, Springer Nature, Standard BioTools Inc., Tecan Group Ltd., Ultivue, Inc., Veracyte, Inc., Veranome Biosystems, LLC, and Vizgen Corporation.

Market Segmentation & Coverage

This research report categorizes the Spatial Genomics & Transcriptomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Instruments, and Software.
• Based on Technology, market is studied across Immunohistochemistry Screening, Spatial Genomics, and Spatial Transcriptomics. The Spatial Genomics is further studied across Biochemical Techniques, Fluorescence in Situ Hybridization, Genome Perturbation Tools, Massively-Parallel Sequencing, and Microscopy-Based Live DNA Imaging. The Spatial Transcriptomics is further studied across In Situ Sequencing, Microtomy Sequencing, Sequencing-Based Methods, and Transcriptome In-vivo Analysis.
• Based on End-Use, market is studied across Academic Institutes, Diagnostic Institutes, Pharmaceutical Manufacturer, and Translational Research.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic diseases and need for designing accurate and effective drugs
    • 5.1.1.2. Improving regulatory and ethical acceptance of genomics and sequencing technologies
    • 5.1.1.3. Emerging use of spatial analysis to advance precision medicine & diagnostics
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness among healthcare professionals about genomic medicine in developing economies
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in spatial biology primarily focused on AI, 3D printing, and standardized diagnostic biomarkers
    • 5.1.3.2. Rising public and private funding for genomics & transcriptomics research
  • 5.1.4. Challenges
    • 5.1.4.1. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Spatial Genomics & Transcriptomics Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instruments
• 6.4. Software

7. Spatial Genomics & Transcriptomics Market, by Technology

• 7.1. Introduction
• 7.2. Immunohistochemistry Screening
• 7.3. Spatial Genomics
  • 7.3.1. Biochemical Techniques
  • 7.3.2. Fluorescence in Situ Hybridization
  • 7.3.3. Genome Perturbation Tools
  • 7.3.4. Massively-Parallel Sequencing
  • 7.3.5. Microscopy-Based Live DNA Imaging
• 7.4. Spatial Transcriptomics
  • 7.4.1. In Situ Sequencing
  • 7.4.2. Microtomy Sequencing
  • 7.4.3. Sequencing-Based Methods
  • 7.4.4. Transcriptome In-vivo Analysis

8. Spatial Genomics & Transcriptomics Market, by End-Use

• 8.1. Introduction
• 8.2. Academic Institutes
• 8.3. Diagnostic Institutes
• 8.4. Pharmaceutical Manufacturer
• 8.5. Translational Research

9. Americas Spatial Genomics & Transcriptomics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Spatial Genomics & Transcriptomics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. OmicsVeu Launches An Extensive Line Of Spatial Biology
  • 12.3.2. Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022
  • 12.3.3. Lexogen Introduces CORALL RNA-Seq V2 - a fast and flexible whole transcriptome RNA-Seq Library Prep Kit.
  • 12.3.4. NanoString Launches New nCounter Pro Analysis System
  • 12.3.5. Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
  • 12.3.6. Fulgent Genetics Announces Strategic Investment in Spatial Genomics
  • 12.3.7. Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform
  • 12.3.8. Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
  • 12.3.9. Andor and Akoya Biosciences to Collaborate in Spatial Omics market
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10X Genomics, Inc.
• 2. Akoya Biosciences, Inc.
• 3. Arima Genomics, Inc.
• 4. AtlasXomics Inc.
• 5. Axcelead Drug Discovery Partners Inc.
• 6. BGI Australia
• 7. Bio-Techne Corporation
• 8. BioSpyder Technologies Inc.
• 9. Bruker Corporation
• 10. Bucher Biotec AG
• 11. CD Genomics
• 12. CeGaT GmbH
• 13. Dovetail Genomics, LLC
• 14. Easi-Genomics
• 15. Enzo Life Sciences, Inc.
• 16. Eurofins Genomics
• 17. Fulgent Genetics
• 18. Genomic Vision SA
• 19. Illumina, Inc.
• 20. Indivumed Group
• 21. Ionpath, Inc.
• 22. Lunaphore Technologies S.A.
• 23. Miltenyi Biotec
• 24. Nanostring Technologies, Inc.
• 25. Natera Inc.
• 26. Novogene Co, Ltd.
• 27. Oxford Nanopore Technologies PLC
• 28. PerkinElmer, Inc.
• 29. PT Pandu Biosains
• 30. Rarecyte, Inc
• 31. Rebus Biosystems, Inc.
• 32. Resolve Biosciences GmbH
• 33. S2 Genomics, Inc.
• 34. Seven Bridges Genomics
• 35. Single Cell Discoveries
• 36. Single Technologies AB
• 37. Singular Genomics System, Inc.
• 38. Spatial Genomics
• 39. Springer Nature
• 40. Standard BioTools Inc.
• 41. Tecan Group Ltd.
• 42. Ultivue, Inc.
• 43. Veracyte, Inc.
• 44. Veranome Biosystems, LLC
• 45. Vizgen Corporation